Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACON

Aclarion Inc

Nov 14 • 04:00PM ET

6.16

+0.01 0.16 %

Healthcare • Health Information Services • USA • NASD

Peers: ABT GEHC HOLX SRTS CUTR IRIX AXGN LUMO TRIB OSUR

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1602.94	Insider Own	0.00%	Shs Outstand	0.58M	Perf Week	-14.80%
Market Cap	4.14M	Forward P/E	-	EPS next Y	-13.33	Insider Trans	-	Shs Float	-	Perf Month	-29.20%
Enterprise Value	-7.23M	PEG	-	EPS next Q	-2.64	Inst Own	0.28%	Short Float	-	Perf Quarter	-15.36%
Income	-7.39M	P/S	59.14	EPS this Y	99.80%	Inst Trans	1.54%	Short Ratio	0.27	Perf Half Y	-11.24%
Sales	0.07M	P/B	0.29	EPS next Y	11.60%	ROA	-89.50%	Short Interest	0.04M	Perf YTD	-99.53%
Book/sh	21.46	P/C	0.36	EPS next 5Y	-	ROE	-97.72%	52W High	3499.51 -99.82%	Perf Year	-99.63%
Cash/sh	16.92	P/FCF	-	EPS past 3/5Y	60.35% 40.18%	ROIC	-59.10%	52W Low	6.15 0.16%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.81% 11.20%	Gross Margin	-331.37%	Volatility	6.74% 5.31%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-103.29	EPS Y/Y TTM	92.19%	Oper. Margin	-10173.70%	ATR (14)	0.48	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	16.93	Sales Y/Y TTM	36.91%	Profit Margin	-10948.19%	RSI (14)	28.05	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	16.93	EPS Q/Q	99.78%	SMA20	-17.06%	Beta	1.43	Target Price	22.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	31.48%	SMA50	-20.92%	Rel Volume	0.18	Prev Close	6.15
Employees	6	LT Debt/Eq	0.00	Earnings	Aug 22	SMA200	-74.36%	Avg Volume	135.02K	Price	6.16
IPO	Apr 22, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	-21.68% -33.33%	Trades		Volume	24,750	Change	0.16%

Nov-05-25 06:00AM	Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion (GlobeNewswire)
Oct-22-25 06:00AM	Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH (GlobeNewswire)
Oct-14-25 06:09AM	Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst (GlobeNewswire) -7.64%
Oct-13-25 06:00AM	Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference (GlobeNewswire) +12.71%
Oct-09-25 06:00AM	Aclarion to Present at the LD Micro Main Event XIX (Newsfile) -5.39%
06:00AM	Loading…
Oct-07-25 06:00AM	Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH (GlobeNewswire)
Oct-01-25 07:17AM	Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers (GlobeNewswire)
Sep-25-25 06:00AM	First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial (GlobeNewswire)
Sep-03-25 06:00AM	Aclarion Appoints Greg Gould as Chief Financial Officer (GlobeNewswire)
Aug-07-25 06:05PM	AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 06:00AM	Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring (GlobeNewswire) +5.71%
06:00AM	Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts (GlobeNewswire)
Jul-07-25 04:01PM	Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-25-25 06:00AM	First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial (GlobeNewswire)
Jun-24-25 07:00AM	Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum (GlobeNewswire)
06:00AM	Loading…
Jun-10-25 06:00AM	Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site (GlobeNewswire)
May-20-25 06:00AM	Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site (GlobeNewswire)
May-12-25 07:34AM	Aclarion Announces Texas Back Institute as New CLARITY Trial Site (GlobeNewswire) +7.04%
May-05-25 06:00AM	Aclarion Welcomes Advocate Health as CLARITY Trial Site (GlobeNewswire)
Apr-29-25 06:00AM	Aclarion Announces Commercial Agreement with Spine Institute of Louisiana (GlobeNewswire)
Apr-23-25 06:00AM	Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 (GlobeNewswire)
Apr-21-25 06:00AM	Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis (GlobeNewswire) -11.69%
Apr-09-25 07:00AM	Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub (GlobeNewswire) +9.85%
Apr-02-25 06:00AM	Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California (GlobeNewswire) +11.49%
Mar-31-25 07:00AM	Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives (GlobeNewswire) -10.89%
Mar-26-25 07:00AM	Aclarion Announces Reverse Stock Split (GlobeNewswire) -23.03%
Mar-13-25 09:25AM	Aclarion Provides Shareholder Update (GlobeNewswire) -15.94%
Mar-07-25 09:45AM	Aclarion announces expansion plans with RadNet affiliates in NY, NJ (TipRanks) -13.75%
Mar-06-25 09:35AM	Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey (GlobeNewswire) -77.14%
Mar-03-25 06:00AM	Aclarion Announces First Commercial Agreement with Scripps Health (GlobeNewswire) +126.87%
04:01PM	Loading…
Feb-28-25 04:01PM	Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders (GlobeNewswire) +27.38%
Feb-20-25 12:31PM	Aclarion, Inc. (ACON) to Showcase NOCISCAN's Impact on Spine Surgery at 2025 Spine Summit (Insider Monkey) +16.85%
06:00AM	Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit (GlobeNewswire)
Feb-11-25 07:58AM	Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body (GlobeNewswire) -10.28%
Feb-06-25 07:23AM	Aclarion Announces Northwestern Medicine as First CLARITY Trial Site (GlobeNewswire)
Feb-04-25 07:23AM	Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded (GlobeNewswire)
Jan-31-25 11:59AM	Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference (GlobeNewswire) -15.48%
Jan-30-25 03:13PM	Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market (NewMediaWire) -8.82%
Jan-28-25 10:51AM	Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split (NewMediaWire) -17.02%
Jan-24-25 05:30PM	Aclarion Announces Reverse Stock Split (NewMediaWire) +27.08% -30.42%
Jan-17-25 04:43PM	Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants (NewMediaWire) -6.00%
Jan-15-25 09:15AM	Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants (NewMediaWire) -55.64%
Jan-07-25 07:28AM	Aclarion, Inc. Raises Funds Through Stock Offering (TipRanks) -6.70%
Jan-03-25 04:11PM	Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market (NewMediaWire) +110.14% -42.96%
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-21-24 08:00AM	Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash (GlobeNewswire)
Nov-14-24 05:00PM	Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st (ACCESSWIRE)
Oct-10-24 07:00AM	Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Sep-27-24 06:57AM	Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes (GlobeNewswire)
Sep-13-24 08:30AM	PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology (GlobeNewswire)
Sep-12-24 06:57AM	Aclarion Provides Corporate Update on Nociscan AI Technology Milestones (GlobeNewswire) +15.38%
06:00AM	Transforming Oncology: Stocks to Watch in the Oncology Sector (News Direct)
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
06:00AM	Aclarion, Inc.'s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector (News Direct)
Sep-10-24 06:57AM	Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial (GlobeNewswire)
Sep-06-24 11:27AM	Aclarion Added to PRISM Emerging Medical Devices Index (GlobeNewswire)
Sep-05-24 06:57AM	Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market (GlobeNewswire) -6.49%
Aug-29-24 06:57AM	Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey (GlobeNewswire) -5.20%
Aug-21-24 07:57AM	Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans (GlobeNewswire)
Aug-15-24 09:48AM	Aclarion to Present at August 20th Virtual Investor Summit Microcap Event (GlobeNewswire) +10.48%
Aug-14-24 08:08AM	Aclarion Announces First Commercial Agreement in Michigan (GlobeNewswire) -10.27%
Aug-13-24 09:07AM	Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK (GlobeNewswire) -16.98%
Jul-09-24 07:00AM	Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK (GlobeNewswire)
Jun-26-24 08:30AM	Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK (GlobeNewswire) +6.34%
Jun-25-24 08:30AM	Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London (GlobeNewswire)
Jun-20-24 08:00AM	Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution (NewMediaWire)
Jun-18-24 07:00AM	Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution (NewMediaWire)
May-15-24 10:55PM	ACON Stock Earnings: Aclarion Reported Results for Q1 2024 (InvestorPlace) +17.99%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -11.57%
Apr-25-24 09:14AM	Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain (GlobeNewswire) +36.35%
Apr-23-24 08:00AM	Aclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 (NewMediaWire)
Mar-04-24 08:00AM	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs (GlobeNewswire) +10.18%
Feb-27-24 03:22PM	Aclarion Announces Closing of $3.0 Million Public Offering (GlobeNewswire)
Feb-26-24 09:15AM	Aclarion Announces Pricing of $3.0 Million Public Offering (GlobeNewswire) -60.59%
08:42AM	Why Is Aclarion (ACON) Stock Down 19% Today? (InvestorPlace)
Feb-05-24 08:00AM	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership (GlobeNewswire)
Jan-29-24 09:31AM	Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion? (PR Newswire) -11.97%
09:17AM	Why Is Aclarion (ACON) Stock Down 16% Today? (InvestorPlace)
Jan-26-24 07:58AM	Why Is Aclarion (ACON) Stock Up 109% Today? (InvestorPlace) +52.28%
Jan-22-24 08:00AM	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD (GlobeNewswire) -7.12%
Jan-17-24 08:00AM	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution (GlobeNewswire) +5.70%
Jan-08-24 08:00AM	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan (GlobeNewswire) +17.65%
Jan-02-24 12:00PM	Aclarion Announces Reverse Stock Split (GlobeNewswire)
Nov-27-23 08:00AM	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams (GlobeNewswire)
Nov-08-23 08:00AM	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption (GlobeNewswire) +7.69%
Nov-06-23 08:00AM	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD (GlobeNewswire)
Nov-01-23 08:00AM	Aclarion Presents at the NIH HEAL Initiative Fall Meeting (GlobeNewswire) -6.90%
Oct-25-23 08:30AM	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver (GlobeNewswire) +42.86%
Oct-24-23 08:45AM	Aclarion Announces Nociscan Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting (GlobeNewswire) -10.56%
Oct-23-23 07:00AM	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan (GlobeNewswire) -36.28%
Oct-02-23 08:00AM	Aclarion Provides Updated Investor Presentation and Corporate Update (GlobeNewswire) +25.90%
Aug-25-23 04:10PM	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report (GlobeNewswire)
Jun-14-23 11:27AM	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI (GlobeNewswire)
Jun-08-23 07:30AM	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting (GlobeNewswire) +23.08%
May-30-23 07:30AM	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic (GlobeNewswire) +77.97%
May-23-23 07:30AM	Aclarions Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD (GlobeNewswire) -9.91%
07:00AM	Aclarion, Inc. Announces Delayed 10-Q Filing (GlobeNewswire)
May-19-23 07:30AM	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts (GlobeNewswire)
May-11-23 12:41PM	Aclarion providing less invasive solution to treat lo back pain through augmented intelligence (News Direct)
May-02-23 07:00AM	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain (GlobeNewswire) -5.81%

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACON

Aclarion Inc

Upgrade your FINVIZ experience